Filgotinib

Filgotinib is a medication designed to reduce inflammation by targeting specific pathways involved in immune responses. It belongs to a class called Janus kinase (JAK) inhibitors, which help control conditions like rheumatoid arthritis and inflammatory bowel disease by interfering with molecules that promote inflammation. By modulating these signals, Filgotinib can lessen symptoms such as pain, swelling, and joint damage. It is taken orally and is typically prescribed when other treatments have not been effective. Its goal is to improve quality of life by managing chronic inflammatory symptoms more effectively.